Search Results - "Reijke, T. M."

Refine Results
  1. 1

    A scalable hyperthermic intravesical chemotherapy (HIVEC) setup for rat models of bladder cancer by Van Hattum, J. W., Scutigliani, E. M., Helderman, R. F. C. P. A., Zweije, R., Rodermond, H. M., Oei, A. L., Crezee, J., Oddens, J. R., De Reijke, T. M., Krawczyk, P. M.

    Published in Scientific reports (29-04-2022)
    “…Hyperthermic intravesical chemotherapy (HIVEC)—whereby the bladder is heated to ± 43 °C during a chemotherapy instillation—can improve outcomes of non-muscle…”
    Get full text
    Journal Article
  2. 2

    Work ability and return-to-work in cancer patients by de Boer, A G E M, Verbeek, J H A M, Spelten, E R, Uitterhoeve, A L J, Ansink, A C, de Reijke, T M, Kammeijer, M, Sprangers, M A G, van Dijk, F J H

    Published in British journal of cancer (22-04-2008)
    “…The extent to which self-assessed work ability collected during treatment can predict return-to-work in cancer patients is unknown. In this prospective study,…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    The additional value of blood cultures in patients with complicated urinary tract infections by Spoorenberg, V., Prins, J.M., Opmeer, B.C., de Reijke, T.M., Hulscher, M.E.J.L., Geerlings, S.E.

    Published in Clinical microbiology and infection (01-08-2014)
    “…We evaluated 800 hospitalized patients with a complicated urinary tract infection, from whom both a blood and a urine culture were obtained on the first day of…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Fluorescence in situ hybridization in 1 mL of selective urine for the detection of upper tract urothelial carcinoma: a feasibility study by Freund, J. E., Liem, E. I. M. L., Savci-Heijink, C. D., de Reijke, T. M.

    “…Kidney-sparing surgery of upper tract urothelial carcinoma (UTUC) requires a stringent follow-up with frequent ureteroscopies. Triage testing could reduce the…”
    Get full text
    Journal Article
  9. 9

    Cancer, fatigue and the return of patients to work—a prospective cohort study by Spelten, E.R., Verbeek, J.H.A.M., Uitterhoeve, A.L.J., Ansink, A.C., van der Lelie, J., de Reijke, T.M., Kammeijer, M., de Haes, J.C.J.M., Sprangers, M.A.G.

    Published in European journal of cancer (1990) (01-07-2003)
    “…Fatigue is a highly prevalent and debilitating symptom in cancer survivors. The aim of this study was to assess the impact of fatigue and other cancer-related…”
    Get full text
    Journal Article
  10. 10

    Phase 2 study of adjuvant intravesical instillations of apaziquone for high risk nonmuscle invasive bladder cancer by Hendricksen, K, Cornel, E B, de Reijke, T M, Arentsen, H C, Chawla, S, Witjes, J A

    Published in The Journal of urology (01-04-2012)
    “…We studied the safety and efficacy of multiple adjuvant apaziquone instillations in patients with high risk nonmuscle invasive bladder cancer. Patients with…”
    Get more information
    Journal Article
  11. 11

    Appropriate antibiotic use for patients with complicated urinary tract infections in 38 Dutch Hospital Departments: a retrospective study of variation and determinants by Spoorenberg, V, Geerlings, S E, Geskus, R B, de Reijke, T M, Prins, J M, Hulscher, M E J L

    Published in BMC infectious diseases (09-11-2015)
    “…Appropriate antibiotic use in patients with complicated urinary tract infections can be measured by a valid set of nine quality indicators (QIs). We evaluated…”
    Get full text
    Journal Article
  12. 12

    Tamsulosin 0.4 mg once daily: effect on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction by Höfner, K, Claes, H, De Reijke, T M, Folkestad, B, Speakman, M J

    Published in European urology (01-10-1999)
    “…To evaluate the effect of tamsulosin, 0.4 mg once daily, on sexual function in comparison with placebo and alfuzosin, 2.5 mg three times daily, in patients…”
    Get more information
    Journal Article
  13. 13

    Prostate cancer treated by anti-androgens: is sexual function preserved? by SCHRÖDER, F. H, COLLETTE, L, DE REIJKE, T. M, WHELAN, P

    Published in British journal of cancer (01-01-2000)
    “…This paper reports on results of the EORTC protocol 30892, an open, prospective, randomized study of 310 patients with previously untreated metastatic prostate…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Histopathological Outcomes after Irreversible Electroporation for Prostate Cancer: Results of an Ablate and Resect Study by van den Bos, W, Jurhill, R.R, de Bruin, D.M, Savci-Heijink, C.D, Postema, A.W, Wagstaff, P.G.K, Muller, B.G, Varkarakis, I.M, Skolarikos, A, Zondervan, P.J, Laguna Pes, M.P, de Reijke, T.M, de la Rosette, J.J.M.C.H

    Published in The Journal of urology (01-08-2016)
    “…Purpose Irreversible electroporation is a tissue ablation modality that uses high voltage electric energy to induce an increase in cell membrane permeability…”
    Get full text
    Journal Article
  16. 16

    Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer by Ripping, T M, Rammant, E, Witjes, J A, Aaronson, N K, van Hemelrijck, M, van Hoogstraten, L M C, Kiemeney, L A, Aben, K K H

    Published in Health and quality of life outcomes (29-12-2022)
    “…Quality of Life (QoL) of bladder cancer patients has been largely neglected. This is partly due to the lack of well-validated QoL questionnaires. The aim of…”
    Get full text
    Journal Article
  17. 17

    Improving hyperthermia treatment planning for the pelvis by accurate fluid modeling by Schooneveldt, G., Kok, H. P., Balidemaj, E., Geijsen, E. D., van Ommen, F., Sijbrands, J., Bakker, A., de la Rosette, J. J. M. C. H., Hulshof, M. C. C. M., de Reijke, T. M., Crezee, J.

    Published in Medical physics (Lancaster) (01-10-2016)
    “…Purpose: Hyperthermia is an established (neo)adjuvant treatment modality for a number of pelvic malignancies. Optimal treatment of these tumors requires robust…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Current status of minimally invasive treatment options for localized prostate carcinoma by Beerlage, H P, Thüroff, S, Madersbacher, S, Zlotta, A R, Aus, G, de Reijke, T M, de la Rosette, J J

    Published in European urology (01-01-2000)
    “…Prostate cancer is the leading malignancy in men today and an increase in detected localized prostate cancers is expected in the years to come. Even though…”
    Get more information
    Journal Article